SCP20: Kenyan intervention on Patents and Health
20TH Session of the Standing Committee on the Law of PatentsStatement by Kenya
Agenda Item No. 8: Patents and Health, 28th January 2014
Thank you Mr. Chairman for giving Kenya the floor.
Kenya supports the statement made by Algeria on behalf of the African Group and the proposal put forward by the Group and the DAG.
EB134: Statement of South Africa on Access to Essential Medicines (in the wake of Pharmagate)
On Thursday, 23 January 2014, Malebona Precious Matsoso (Director General of the South African National Department of Health) delivered the the following intervention at the 134th session of the World Health Organization’s Executive Board under agenda item 9.7 on Access to essential medicines in response to the recent Pharmagate imbroglio.
New leaked Merck missive reveals deep drug, medical device company opposition to South African patent reforms
James K. Glassman. Merck said Glassman’s public relations firm was selected by PhRMA to lead a campaign to keep drug prices high in South Africa. The Health Minister in South Africa referred to the campaign proposal as a genocidal conspiracy of satanic magnitude. 2007 Report and Decision of WIPO General Assembly on Diplomatic Conference for Broadcasting Organizations
WO/GA/34/16
ITEM 17 OF THE CONSOLIDATED AGENDA:
REPORT ON THE SPECIAL SESSIONS OF THE STANDING COMMITTEE ON COPYRIGHT AND RELATED RIGHTS REGARDING THE PROPOSED DIPLOMATIC CONFERENCE ON THE PROTECTION OF THE RIGHTS OF BROADCASTING ORGANIZATIONS
202 Discussions were based on document WO/GA/34/8.
203 Referring to document WO/GA/34/8, the Secretariat summarized the previous discussions and the recommendation from the Second Special Session of the Standing Committee on Copyright and Related Rights (SCCR).
WIPO hosts Conference on Open Innovation: Collaborative Projects and the Future of Knowledge (22-23 January 2014)
The World Intellectual Property Organization (WIPO) will host a “Conference on Open Innovation: Collaborative Projects and the Future of Knowledge” on 22-23 January 2014 at its headquarters in Geneva, Switzerland.
The origins of this conference on open collaborative development models is predicated upon Recommendation 36 of the WIPO Development Agenda which states:
Fast track trade bill fails to correct asymmetric secrecy of trade negotiations
Today Senators Bacus and Hatch introduced fast track legislation in the Senate. The words transparent or transparency appear 17 times in the 107 page bill, but only twice in connection with “Trade Institution Transparency.”
AstraZeneca’s 20-F, section on Risk Factors, for fiscal year ended December 31, 2012
From AstraZeneca’s 20-F, section on Risk Factors, for fiscal year ended December 31, 2012. Number of words in Item 1A: 8621 Compulsory licensing of patents: 45 3D. Risk Factors The information (including tabular data) set forth or referenced under the… Continue Reading
Amgen’s 10-K, section on Risk Factors, for fiscal year ended December 31, 2012
From Amgen’s 10-K, section on Risk Factors, for fiscal year ended December 31, 2012.
Item 1A. RISK FACTORS
Gilead’s 10-K, section on Risk Factors, for fiscal year ended December 31, 2012
From Gilead’s 10-K, section on Risk Factors, for fiscal year ended December 31, 2012.
Number of words in section 1A: 12709
Words on compulsory licenses: 396ITEM 1A. RISK FACTORS
Johnson & Johnson’s 10-K, section on Risk Factors, for fiscal year ended December 31, 2012.
From Johnson & Johnson’s 10-K, section on Risk Factors, for fiscal year ended December 31, 2012.
Number of words in Item 1A: 1314
Compulsory licensing of patents: 0Item 1A.RISK FACTORS
